Peptide receptor radionuclide therapy (PRRT): clinical significance of re-treatment?
Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria. irene.virgolini@i-med.ac.at.
Irene
I
Virgolini
D006801:Humans; D018358:Neuroendocrine Tumors / Q000188:drug therapy; D015282:Octreotide / Q000627:therapeutic use*; D016499:Radioimmunotherapy; D011868:Radioisotopes / Q000627:therapeutic use; D018000:Receptors, Peptide / Q000627:therapeutic use*
D011868:Radioisotopes; D018000:Receptors, Peptide; D015282:Octreotide